March 18, 2013

Mayo Clinic to hold trial for BrainStorm’s ALS stem cell therapy

By Logan Lafferty

BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company's adult stem cell treatment for ALS. The Mayo Clinic is the third leading U.S. clinical site to sign a letter of understanding, following the University of Massachusetts and Massachusetts General, BrainStorm said on Monday.

Additional Coverage: Yahoo! News, Chicago Tribune



Tags: A.L.S., BrainStorm Cell Therapeutics, clinical trial, Industry News & Competitive Intelligence, Mayo Clinic Rochester, Research, Reuters, stem cell therapy, stem-cell

Contact Us · Privacy Policy